Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.9% in the fourth quarter, Holdings Channel reports. The fund owned 26,511 shares of the company’s stock after selling 1,072 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Henry Schein were worth $1,835,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Xponance Inc. increased its stake in Henry Schein by 1.7% during the 4th quarter. Xponance Inc. now owns 19,240 shares of the company’s stock worth $1,331,000 after purchasing an additional 315 shares in the last quarter. Thrivent Financial for Lutherans increased its position in shares of Henry Schein by 10.8% during the fourth quarter. Thrivent Financial for Lutherans now owns 116,843 shares of the company’s stock worth $8,085,000 after acquiring an additional 11,428 shares in the last quarter. Cibc World Markets Corp raised its holdings in shares of Henry Schein by 0.7% during the fourth quarter. Cibc World Markets Corp now owns 369,746 shares of the company’s stock worth $25,586,000 after acquiring an additional 2,440 shares during the period. Brandes Investment Partners LP raised its holdings in shares of Henry Schein by 10.9% during the fourth quarter. Brandes Investment Partners LP now owns 9,367 shares of the company’s stock worth $648,000 after acquiring an additional 918 shares during the period. Finally, Essential Planning LLC. acquired a new position in Henry Schein in the 4th quarter worth $934,000. Institutional investors and hedge funds own 96.62% of the company’s stock.
Henry Schein Trading Down 2.0 %
Henry Schein stock opened at $69.38 on Wednesday. The stock has a 50-day simple moving average of $74.79 and a 200 day simple moving average of $72.65. The stock has a market capitalization of $8.62 billion, a P/E ratio of 28.55, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.
Analyst Ratings Changes
Several analysts have issued reports on the company. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Jefferies Financial Group lifted their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Finally, Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and a consensus target price of $81.10.
Check Out Our Latest Research Report on Henry Schein
Insider Activity
In other news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
- Five stocks we like better than Henry Schein
- Why Invest in 5G? How to Invest in 5G Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to start investing in penny stocks
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Find and Profitably Trade Stocks at 52-Week Lows
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.